Notify me when M.D. Ph.D. Hoyoung Huh files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics, Plc | Ordinary Shares, $0.0001 par value | 16% | $11,612,311,200 | 8,294,508,000 | Hoyoung Huh, M.D., Ph.D. | 14 Nov 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|